Loading...
FEBRUARY 22, 2021
Email
Linkedin
Facebook
Twitter
Copy LinkThe COVID-19 vaccines are being rolled out in an environment where demand for the vaccine exceeds supply, with new strains of the virus emerging, and there is a multiplicity of constantly-changing rules that vary by country, state, and locality.
In this environment, companies are faced with a whole new set of challenges relating to staying on top of health and scientific developments; monitoring and abiding by different regulations; setting policies regarding the vaccine for employees, customers, and business partners; communicating with stakeholders; preparing for potential litigation; and having the right board governance and decision-making processes in place.
Join this webcast for a deep-dive into the legal and governance challenges of the COVID-19 vaccine.
As an attendee of this webcast, you will:
Who Should Attend: C-suite executives, (deputy/associate) general counsel, (assistant) corporate secretaries, investors, attorneys, and other governance professionals.
Governance Watch offers summaries and concise perspectives on issues affecting corporate democracy, shareholder communications, and relationships, fiduciary obligations of directors, disclosure, compensation, and insider trading.
This On-Demand Webcast is Complimentary.
